Philip Butler is the Founder and CEO of MbeleMed, a health technology company transforming how silent cardiovascular disease is detected. A Wharton MBA and former private equity investor, Philip previously led the majority acquisition of a remote cardiac monitoring company, where he recognized that the greatest challenge was not monitoring technology—it was identifying who should be screened. Inspired by his father's missed atrial fibrillation diagnosis, he founded MbeleMed to help health systems and Medicare Advantage plans detect silent cardiac risk earlier through AI-informed risk stratification, existing wearable infrastructure, and a pay-on-confirmed-detection model.